Iovance Biotherapeutics, Inc.
Clinical trials sponsored by Iovance Biotherapeutics, Inc., explained in plain language.
-
Immune cell attack: new hope for advanced cervical cancer?
Disease control TerminatedThis study tested a personalized treatment called LN-145 for people with cervical cancer that had come back or spread. The treatment uses a patient's own immune cells (tumor-infiltrating lymphocytes) that are grown in a lab and then given back to fight the cancer. The trial aimed…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 11:56 UTC
-
Can your own tumor cells beat cancer? new trial puts immune cells to the test
Disease control TerminatedThis study tested a treatment that takes immune cells from a patient's own tumor, grows them in a lab, and gives them back to fight cancer. It included 225 adults with advanced melanoma, head and neck, or lung cancer. The goal was to see if these cells could shrink tumors and how…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC